MarketBeat on MSN
Twist Bioscience Q3 Earnings Call Highlights
Twist Bioscience (NASDAQ:TWST) reported fiscal 2026 third-quarter revenue of $118.4 million, up 23% from a year earlier, ...
China has reverse-engineered the battery, the software, the chassis and now the V8. The only thing it hasn't cracked is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results